Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | 923天前
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

read more
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market moves on Friday, adding to the losses in the previous three sessions, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the psychological 8,000 mark, with weakness across most sectors led by financial and technology stocks.
RTTNews | 5小时6分钟前
Japanese Market Sharply Lower

Japanese Market Sharply Lower

Giving up the gains in the previous two sessions, the Japanese market is sharply lower on Friday, following the broadly negative cues from Wall Street overnight. The Nikkei 225 is falling below the 37,100 level, with weakness across most sectors led by index heavyweights, exporters and technology stocks.
RTTNews | 6小时19分钟前
Australian Market Sharply Lower

Australian Market Sharply Lower

The Australian stock market is trading sharply lower on Friday, extending the losses in the previous three sessions, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the psychological 8,000 mark, with weakness across most sectors led by financial and technology stocks.
RTTNews | 6小时43分钟前
Dollar Stays Weak Against Most Major Counterparts

Dollar Stays Weak Against Most Major Counterparts

The U.S. dollar stayed weak against most of its major counterparts on Thursday, although the decline was not any significantly pronounced. Traders continued to track the developments on the tariff front, and digested the latest batch of economic data, and the European Central Bank's decision to lower interest rates once again.
RTTNews | 9小时17分钟前
Oil Futures Settle Slightly Higher

Oil Futures Settle Slightly Higher

Oil futures settled slightly higher on Thursday after some wild swings amid uncertainty about the outlook for oil demand, and on possible excess supply in the market.
RTTNews | 10小时53分钟前
U.S. Dollar Weakens As Tariff Concerns Ease

U.S. Dollar Weakens As Tariff Concerns Ease

The U.S. dollar declined against its major counterparts in the New York session on Thursday, as worries about tariffs eased following the Trump administration's decision to delay car tariffs for Canada and Mexico by a month.
RTTNews | 11小时45分钟前